1362243-56-8

Basic information

• Product Name: 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole
• Synonyms: 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole
• CAS NO: 1362243-56-8
• Molecular Formula: C13H18BN3O2
• Molecular Weight: 259.11192
• Mol File: 1362243-56-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 409.0±18.0 °C(Predicted)
• Appearance: /
• Density: 1.17±0.1 g/cm3(Predicted)
• PKA: 1.41±0.30(Predicted)
• CAS DataBase Reference: 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole(1362243-56-8)
• EPA Substance Registry System: 1-Methyl-6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,2,3]triazole(1362243-56-8)

Safety Data

• Hazardous Substances Data: 1362243-56-8(Hazardous Substances Data)

Usage

Structure

Benzotriazole derivative containing a boron atom

Type of compound

Complex chemical compound

Usage

Building block in organic synthesis, protective and stabilizing agent in chemical reactions, used in pharmaceutical and agrochemical industries

Unique property

Boron-containing structure, useful in organometallic chemistry and catalytic reactions.

Upstream product

• 32046-62-1 5-bromo-1H-benzotriazole 
• 73183-34-3 bis(pinacol)diborane 
• 74-88-4 methyl iodide 
• 1083181-43-4 6-bromo-1-methyl-1H-1,2,3-benzotriazole 

Relevant articles and documents

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

SUBSTITUTED QUINOXALINE DERIVATIVES

The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.